Rebecca C Rossom1, Bobbi Jo Yarborough2, Jennifer M Boggs3, Karen J Coleman4, Brian K Ahmedani5, Frances L Lynch2, Yihe Daida6, Gregory E Simon7. 1. Health Partners Institute, 8170 33rd Ave S, MS21112R, Minneapolis, MN 55425, United States. Electronic address: rebecca.c.rossom@healthpartners.com. 2. Kaiser Permanente Northwest, Center for Health Research, Portland, OR, United States. 3. Kaiser Permanente Colorado, Institute for Health Research, Denver, CO, United States. 4. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States. 5. Henry Ford Health System, Center for Health Services Research, Detroit, MI, United States. 6. Kaiser Permanente Center for Integrated Health Care Research, Honolulu, HI, United States. 7. Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Abstract
BACKGROUND: People with bipolar disorder have elevated suicide risk. We estimated the ability of the Patient Health Questionnaire (PHQ9) to predict suicide outcomes for outpatients with bipolar disorder. METHODS: Visits by adults with bipolar disorder who completed a PHQ9 were identified using electronic health record (EHR) data. Bipolar diagnoses and suicide attempts were ascertained from EHR and claims data, and suicide deaths from state and federal records. Depression severity was assessed via the first eight items of the PHQ9, while suicidal ideation was assessed by the ninth item. RESULTS: 37,243 patients made 126,483 visits. Patients reported at least moderate symptoms of depression in 49% and suicidal ideation in 30% of visits. Risk of suicide attempt was 4.21% in the subsequent 90 days for those reporting nearly daily suicidal ideation compared to 0.74% in those reporting none. Patients with nearly daily suicidal ideation were 3.85 (95% CI 3.32-4.47) times more likely to attempt suicide and 13.78 (95% CI 6.56-28.94) times more likely to die by suicide in the subsequent 90 days than patients reporting none. Patients with self-harm in the last year were 8.86 (95% 7.84-10.02) times more likely to attempt suicide in the subsequent 90 days than those without. LIMITATIONS: Our sample was limited to patients completing the PHQ9 and did not include data on some important social risk or protective factors. CONCLUSIONS: The PHQ9 was a robust predictor of suicide. Suicidal ideation reported on the PHQ9 should be considered a strong indicator of suicide risk and prompt further evaluation.
BACKGROUND: People with bipolar disorder have elevated suicide risk. We estimated the ability of the Patient Health Questionnaire (PHQ9) to predict suicide outcomes for outpatients with bipolar disorder. METHODS: Visits by adults with bipolar disorder who completed a PHQ9 were identified using electronic health record (EHR) data. Bipolar diagnoses and suicide attempts were ascertained from EHR and claims data, and suicide deaths from state and federal records. Depression severity was assessed via the first eight items of the PHQ9, while suicidal ideation was assessed by the ninth item. RESULTS: 37,243 patients made 126,483 visits. Patients reported at least moderate symptoms of depression in 49% and suicidal ideation in 30% of visits. Risk of suicide attempt was 4.21% in the subsequent 90 days for those reporting nearly daily suicidal ideation compared to 0.74% in those reporting none. Patients with nearly daily suicidal ideation were 3.85 (95% CI 3.32-4.47) times more likely to attempt suicide and 13.78 (95% CI 6.56-28.94) times more likely to die by suicide in the subsequent 90 days than patients reporting none. Patients with self-harm in the last year were 8.86 (95% 7.84-10.02) times more likely to attempt suicide in the subsequent 90 days than those without. LIMITATIONS: Our sample was limited to patients completing the PHQ9 and did not include data on some important social risk or protective factors. CONCLUSIONS: The PHQ9 was a robust predictor of suicide. Suicidal ideation reported on the PHQ9 should be considered a strong indicator of suicide risk and prompt further evaluation.
Authors: Mark A Ilgen; Amy S B Bohnert; Rosalinda V Ignacio; John F McCarthy; Marcia M Valenstein; H Myra Kim; Frederic C Blow Journal: Arch Gen Psychiatry Date: 2010-11
Authors: Christine Y Lu; Christine Stewart; Ameena T Ahmed; Brian K Ahmedani; Karen Coleman; Laurel A Copeland; Enid M Hunkeler; Matthew D Lakoma; Jeanne M Madden; Robert B Penfold; Donna Rusinak; Fang Zhang; Stephen B Soumerai Journal: Pharmacoepidemiol Drug Saf Date: 2014-02 Impact factor: 2.890
Authors: Ross J Baldessarini; Leonardo Tondo; Paula Davis; Maurizio Pompili; Frederick K Goodwin; John Hennen Journal: Bipolar Disord Date: 2006-10 Impact factor: 6.744
Authors: Kathleen R Merikangas; Robert Jin; Jian-Ping He; Ronald C Kessler; Sing Lee; Nancy A Sampson; Maria Carmen Viana; Laura Helena Andrade; Chiyi Hu; Elie G Karam; Maria Ladea; Maria Elena Medina-Mora; Yutaka Ono; Jose Posada-Villa; Rajesh Sagar; J Elisabeth Wells; Zahari Zarkov Journal: Arch Gen Psychiatry Date: 2011-03
Authors: Bobbi Jo H Yarborough; Scott P Stumbo; Brian Ahmedani; Rebecca Rossom; Karen Coleman; Jennifer M Boggs; Gregory E Simon Journal: J Addict Med Date: 2021 Jan-Feb 01 Impact factor: 3.702
Authors: Barbara Stanley; Gregory K Brown; Lisa A Brenner; Hanga C Galfalvy; Glenn W Currier; Kerry L Knox; Sadia R Chaudhury; Ashley L Bush; Kelly L Green Journal: JAMA Psychiatry Date: 2018-09-01 Impact factor: 21.596